Navigation Links
ProNAi Announces Preclinical Success for PNT2258 Therapeutic -,Curative Events in Xenograft Mice for Difficult-to-Treat,Non-Hodgkin's Lymphoma

LOS ANGELES--(BUSINESS WIRE)--Apr 17, 2007 - ProNAi Therapeutics, Inc., a biopharmaceutical company pioneering a new class of nucleic-acid drugs based on DNA interference (DNAi), today announced that its lead oncology therapeutic candidate, PNT2258, has successfully demonstrated preclinical in vivo efficacy in xenograft mice for a number of human cancers - including curative events for difficult-to-treat Burkitt's Lymphoma.

Dr. Richard D. Gill, President and CEO of ProNAi, said, "Team ProNAi is quite pleased with our early preclinical results for PNT2258. Particularly encouraging is the fact that PNT2258 has shown promising single agent efficacy and combination therapy efficacy and drug-dose response for multiple cancer types including both hematological and solid tumors."

He added, "However, a very exciting development was our discovery that PNT2258, in combination with Rituximab, demonstrated curative events in treating Daudi xenografts of human Burkitt's Lymphoma in mice. The antitumor effect was rapid and durable. We had 70% complete remissions in two groups of animals dosed with PNT2258 and Rituximab."

In developing its DNAi(R)-based therapy, ProNAi reports that its successful establishment of in vivo efficacy for formulated PNT2258 included:

-- Single agent efficacy for DLCL2 Xenografts of Human Non-Hodgkin's Lymphoma

-- Combination therapy efficacy with Docetaxel for Human Hormone Refractory Prostate Cancer Xenograft

-- Combination therapy with Rituximab in Daudi Xenografts of Human Burkitt's Lymphoma

ProNAi's preclinical research will proceed in 2007. Planned studies include IND-enabling toxicology and ADME studies. ProNAi will file the IND for PNT2258 later this year.

About DNAi(R)

DNAi(R) (DNA interference) is a novel approach to targeting genomic DNA using sequence-specific therapeutic oligonucleotides, employing single strands of DNA to target
'"/>




Page: 1 2

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:3/3/2015)... , March 3, 2015  Web Industries, Inc., ... services in the Medical Device, Advanced Composites, Consumer ... named a 3M Medical Specialties Preferred Converter by ... will allow companies to streamline their supply chains ... contact for 3M materials, intermediate converting services, and ...
(Date:3/3/2015)... 03, 2015 Research and Markets ... the "Telemedicine and Mobile Healthcare Solutions, Services, ... 2020" report to their offering. ... all terms that pertain to the use of ... remote clinical/non-clinical healthcare services. They form the ecosystem ...
(Date:3/3/2015)... Today, the Partnership for Prescription Assistance ... research companies, unveiled a redesigned website ... and caregivers with faster, easier access to information ... assistance programs. Since its launch ... engage, educate and empower patients and caregivers to ...
Breaking Medicine Technology:Web Industries Receives 3M Preferred Converter Status 2Global Telemedicine and Mobile Healthcare Solutions, Services, and Devices: Market Analysis and Forecasts 2015 - 2020 2Global Telemedicine and Mobile Healthcare Solutions, Services, and Devices: Market Analysis and Forecasts 2015 - 2020 3Partnership for Prescription Assistance Relaunches Website with New Features for Patients and Caregivers 2
... New Somatropin Formulation Demonstrate Advantages ... Over Existing Once-Daily ... Nottingham, UK-based speciality pharmaceuticals,company, today announced that the successful ... the synthetic human growth,hormone (hGH) somatropin. Trials demonstrated therapeutic ...
... released by The Philadelphia AIDS Consortium:, WHO: ... its network of eleven (11) community-based organization,sites located ... 30 AmeriCorps ACTS members working throughout New,Jersey, Delaware ... 9 a.m. until Noon; Media Focused,Event 10:30 - ...
Cached Medicine Technology:Critical Pharmaceuticals Enter Sustained Release hGH Arena 2Unprecedented 8th Year Start Up of National Direct AmeriCorps Program Access to Care Through Service (ACTS) Parent, Lead Organization The Philadelphia AIDS Consortium and World Health Care Infrastructures 2
(Date:3/3/2015)... 2015 Introducing 3D Digital Technologies ... a recognized leader in Digital Dentistry. Acute precision ... best dental replicas, leaving no room for error ... dental professionals are able to significantly reduce “chair ... deliver remarkable quality while reducing labor and material ...
(Date:3/3/2015)... Splashtop Inc. , the worldwide ... now available for Epson® MoverioTM BT-200 smart glasses. ... Apps Market , iPod, iPhone, and iPad users can ... Epson Moverio smart glasses using Mirroring360, enhancing the user ... The Epson smart glasses have an advanced binocular optical ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Retrofit ... epidemic at America’s leading corporations, today announces the appointment ... senior executive positions. CEO Mary Pigatti has ... innovation and employee engagement for the fast-growing company, which ... to watch for 2015. , “Retrofit is thrilled ...
(Date:3/3/2015)... March 03, 2015 March 3, 2015, My ... 200th episode. The episode was a unique one, not just ... but because it featured two men who were both faced ... At the beginning of the episode, Deierlein said to Collins, ... my radio show, but I’m very excited that you could ...
(Date:3/3/2015)... Hyderabad, India (PRWEB) March 03, 2015 ... conference, speaker and continuing medical education (CME) credit ... comprehensive database for doctors was initially launched in ... the first of its kind in the field ... The second launch of this Denver, Colorado-based start-up ...
Breaking Medicine News(10 mins):Health News:Iverson Dental Labs Introduces 3D Digital Dental Technology for Superior Products 2Health News:Iverson Dental Labs Introduces 3D Digital Dental Technology for Superior Products 3Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 2Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 3Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 2Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 3Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 4Health News:My Positive Perspective Releases Episode #200 With Car Accident and Coma Survivor Nick Collins 2Health News:eMedEvents Launches Online Medical Conference, Speaker and CME Platform in India 2
... portrayals of correct first aid, study suggests , MONDAY, ... the place to learn how to provide proper first ... study says. , Canadian researchers watched some popular medical ... "ER" -- and found that "doctors" and "nurses" on ...
... ... Preserve Liquidity -, , QUEBEC CITY, Feb. 15 /PRNewswire-FirstCall/ ... cancer diagnostic tests and delivering laboratory services, today announced changes to ... will be comprised of two business segments: (1) administrative headquarters in ...
... ... ... Hayes, Inc., the nation’s leading health technology research and consulting company, today announced that ... has joined the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC). The MEDCAC ...
... findings, researchers find , MONDAY, Feb. 15 (HealthDay News) -- ... not perfect, in determining whether a child has the flu, ... both the seasonal flu and the H1N1 flu that recently ... assistant professor of pediatrics at Baylor College of Medicine in ...
... , SALT LAKE CITY , ... (AAPC) announced its 2010 National Conference being held at the Gaylord ... annual event draws thousands of attendees including doctors, medical coders and office/practice ... for the first time this conference has been approved for 15.75 (CME) ...
... ... made cars and trucks to accelerate when the driver is trying to slow down. ... New York, NY (PRWEB) February ... 21, because the company learned that accelerator pads may stick, causing the vehicle to speed ...
Cached Medicine News:Health News:TV Shows Often Botch Proper Seizure Responses 2Health News:DiagnoCure announces optimization of entreprise structure 2Health News:DiagnoCure announces optimization of entreprise structure 3Health News:DiagnoCure announces optimization of entreprise structure 4Health News:Hayes Announces Appointment Of Dr Susan Levine To The Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) 2Health News:Rapid Flu Test Most Accurate for Young Kids 2Health News:Rapid Flu Test Most Accurate for Young Kids 3Health News:AAPC to Host 18th Annual National Conference in Nashville 2Health News:AAPC to Host 18th Annual National Conference in Nashville 3Health News:Toyota Recalls Millions of Defective Vehicles 2Health News:Toyota Recalls Millions of Defective Vehicles 3
UST-675-P is our end-fire prostate transducer. Multiple frequencies provide extraordinary imaging capabilities for your diverse patient population, and the biopsy guide enables accurate and fast pros...
Our most versatile transducer for superficial imaging. Wide Band, Super High Density, multi-frequency transducer with superb Doppler and color flow sensitivity make this an excellent choice for breas...
... Linear high frequency ... breast and superficial ... exclusive Hemispheric Sound ... technologies. This multi-frequency ...
The 5539-7.5 linear transducer is a high frequency transducer dedicated to superficial and vascular imaging....
Medicine Products: